Therapy News and Research

RSS

Ways to prevent, treat knee and hip joint pain

In the past four weeks, more than one-third of people over the age of 55 in the United States have complained about hip or knee pain to their physician. In a lifetime, our hips and knees get a lot of use. There are various ways individuals can reduce the strain placed on their joints to maintain the health of their hips and knees.

8 Jun 2016

PCP screening could be effective way to improve early melanoma diagnosis

Skin cancer screenings performed by primary care physicians (PCPs) during routine office visits improve the detection of potentially deadly melanomas and find them in earlier stages, according to new research from the University of Pittsburgh School of Medicine.

8 Jun 2016

Study challenges notion of fear of weight gain in patients with anorexia nervosa

A study from Inserm, Paris Descartes University and Sainte Anne Hospital suggests that anorexia nervosa might not be explained by fear of gaining weight, but by the pleasure of losing it... and that the phenomenon might be genetically influenced.

8 Jun 2016

Common angina drug can stimulate patient's own white blood cells to combat cryptococcosis

A drug, more commonly used in the treatment of angina, could be the focus of a new strategy in fighting the fatal fungal infection cryptococcosis

8 Jun 2016

Cerebral microbleeds warn of dementia risk

A high cerebral microbleed count increases an individual's risk of cognitive deterioration and dementia, study results indicate.

8 Jun 2016

Subcutaneous treatment with cord blood stem cells improves eczema symptoms

A new study suggests that treatment with stem cells from umbilical cord blood might be an effective therapy for patients with moderate-to-severe eczema, or atopic dermatitis.

7 Jun 2016

Nivolumab drug benefits metastatic RCC patients who continued treatment beyond progression

In a large randomized study, the immunotherapy drug nivolumab, a checkpoint inhibitor, was shown to be a safe and effective therapy for kidney cancer even in patients who continued treatment after their disease progressed.

7 Jun 2016

Two autologous stem-cell transplants improve survival of children with high-risk neuroblastoma

Children with high-risk neuroblastoma whose treatment included two autologous stem-cell transplants were more likely to be free of cancer three years later than patients who underwent a single transplant, a Phase 3 clinical trial has found.

7 Jun 2016

Scientists discover unexpected functions of snoRNAs that explains cause of some diseases

Scientists have discovered unexpected functions of small nucleolar RNAs (snoRNAs) that explain the cause of some diseases.

7 Jun 2016

Personalized therapy shows improved response in cancer patients

In a meta-analysis of hundreds of clinical trials involving thousands of patients, researchers at University of California San Diego School of Medicine report that therapeutic approaches using precision medicine, which emphasizes the use of individual genetics to refine cancer treatment, showed improved response and longer periods of disease remission, even in phase I trials.

7 Jun 2016

Rice study takes deeper look at how inflammation bridges stress and diabetes

A Rice University study has found a link between emotional stress and diabetes, with roots in the brain's ability to control anxiety.

7 Jun 2016

Scientists develop non-toxic transplantation procedure using antibodies to target blood stem cells in mice

Harvard Stem Cell Institute scientists have taken the first steps toward developing a treatment that would make bone marrow - blood stem cell - transplantation safer and, as a result, more widely available to the millions of people living with blood disorders like sickle cell anemia, thalassemia, and AIDS.

7 Jun 2016

Overtesting for HbA1C levels can increase risk of severe hypoglycemia

With a more-is-better mindset common in society, frequent commercials encouraging checks of glycated hemoglobin (HbA1C) levels, and ads for new diabetes medications to lower HbA1C in adults with Type 2 diabetes, Mayo Clinic researchers were not too surprised to find overtesting occurring.

7 Jun 2016

Coagadex now available for rare bleeding disorder patients in the UK

Bio Products Laboratory, Limited (BPL) today announced that Coagadex is now available for patients in the UK.

7 Jun 2016

Existing immunotherapy drug pembrolizumab shows promise for specific sarcoma subtypes

An existing cancer immunotherapy drug reduces tumor size in some types of rare connective tissue cancers, called sarcomas, report researchers at the University of Pittsburgh Cancer Institute.

7 Jun 2016

New systems-based strategy may help accelerate TB drug discovery

The rise in multi-drug resistant (MDR) and extremely drug resistant (XDR) strains of Mycobacterium tuberculosis (MTB) is becoming a major cause of global health concern for treating tuberculosis, which affects a third of the global population.

7 Jun 2016

Study shows aggressive end-of-life care for young cancer patients may be less effective

In the last month of their lives, younger cancer patients continued to be hospitalized and receive other aggressive treatment at high rates, a University of North Carolina Lineberger Comprehensive Cancer Center-led study found.

7 Jun 2016

Combination immunotherapy may be better than one to combat metastatic melanoma

A new metastatic melanoma study suggests that a combination of two immunotherapies may be better than one.

7 Jun 2016

Pembrolizumab drug shows significant clinical responses in metastatic head and neck cancer patients

Treating head and neck cancer patients with recurrent or metastatic disease with the PD-1 inhibitor pembrolizumab resulted in significant clinical responses in a fifth of the patients from a phase II clinical trial, researchers at the Abramson Cancer Center of the University of Pennsylvania and other institutions reported at the 2016 American Society of Clinical Oncology annual meeting.

7 Jun 2016

Unlocking the first gene to cause otosclerosis: an interview with Dr Ralph Holme

Otosclerosis is a common cause of hearing loss, particularly amongst young adults. It normally starts in their 20s or 30s and it affects about 1 in 200 hundred people. In the UK, about 300,000 people are affected by the condition.

7 Jun 2016

Therapy News and Research

Ways to prevent, treat knee and hip joint pain

PCP screening could be effective way to improve early melanoma diagnosis

Study challenges notion of fear of weight gain in patients with anorexia nervosa

Common angina drug can stimulate patient's own white blood cells to combat cryptococcosis

Cerebral microbleeds warn of dementia risk

Subcutaneous treatment with cord blood stem cells improves eczema symptoms

Nivolumab drug benefits metastatic RCC patients who continued treatment beyond progression

Two autologous stem-cell transplants improve survival of children with high-risk neuroblastoma

Scientists discover unexpected functions of snoRNAs that explains cause of some diseases

Personalized therapy shows improved response in cancer patients

Rice study takes deeper look at how inflammation bridges stress and diabetes

Scientists develop non-toxic transplantation procedure using antibodies to target blood stem cells in mice

Overtesting for HbA1C levels can increase risk of severe hypoglycemia

Coagadex now available for rare bleeding disorder patients in the UK

Existing immunotherapy drug pembrolizumab shows promise for specific sarcoma subtypes

New systems-based strategy may help accelerate TB drug discovery

Study shows aggressive end-of-life care for young cancer patients may be less effective

Combination immunotherapy may be better than one to combat metastatic melanoma

Pembrolizumab drug shows significant clinical responses in metastatic head and neck cancer patients

Unlocking the first gene to cause otosclerosis: an interview with Dr Ralph Holme

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News